Tag: Aclaris Therapeutics Inc

spot_img

Evercore says this biotech stock is a high risk, high reward play

Evercore ISI initiated coverage of Aclaris Therapeutics , a clinical stage biotech working on immunology and inflammation drugs, at an outperform, saying the...